Company Filing History:
Years Active: 1996
Title: The Innovations of Stefan Lindskog
Introduction
Stefan Lindskog is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on galanin antagonists. His research focuses on the physiological functions of galanin and its implications for treating various disorders.
Latest Patents
Stefan Lindskog holds a patent for a galanin antagonist, which is a galanin receptor ligand. This patent describes new peptides, including Galanin (1-12)-Pro-Substance P(5-11), Galanin (1-12)-Pro-Bradykinin(2-9), Galanin (1-12)-Pro-Pro-Pro-(Leu.sup.5 -Enkephalin (5-1), and Galanin (1-12)-Pro-Lys(.epsilon.-NH-)Pro-(Leu5-Enkephalin (5-1). These peptides and their functional analogues are utilized in pharmaceutical preparations to treat disorders in mammals that depend on the physiological function of galanin at the galanin receptor. He has 1 patent to his name.
Career Highlights
Stefan Lindskog is associated with Aktiebolaget Astra, a prominent company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Throughout his career, Stefan has collaborated with esteemed colleagues such as Tamas Bartfai and Tomas H Okfelt. These partnerships have fostered innovation and enhanced research outcomes in their respective fields.
Conclusion
Stefan Lindskog's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of disorders related to galanin, showcasing the importance of research and innovation in medicine.